Navigation Links
Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants
Date:7/28/2008

rned to damaged tissue, leading to an inflammatory response that could result in poor organ function. In the United States, approximately 28,000 patients received a solid organ transplant in 2007.

Orphan drug designation provides an accelerated FDA review process, tax advantages and a seven-year period of market exclusivity in the US upon product approval.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceutical and biological products and drug/device combinations for the critically ill in the hospital and ICU setting. The company's product, INOmax(R) (nitric oxide) for inhalation, is an FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. The drug also is approved by regulatory authorities and used in Canada, Europe, Australia and Latin America. In addition to the ongoing clinical development as well as the marketing and selling of its INOmax product, Ikaria is engaged in a number of Phase 2 trials with Covox(R) (carbon monoxide) for inhalation and Phase 1 trials with hydrogen sulfide (H2S) for various critical care indications. Ikaria has a staff of approximately 400 people and is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI and manufacturing in Port Allen, LA. For more information on Ikaria, please visit http://www.ikaria.com.

CONTACTS: Matthew Bennett, Ikaria, (908) 238-6673, matthew.bennett@ikaria.com; or Jason Rando, The Ruth Group, 646-536-7025, jrando@theruthgroup.com


'/>"/>
SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Artificial Gravity receives 2008 Life Science Book Award
2. Colorado Sen. Ken Salazar receives Soil Stewardship Award
3. Childrens Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach
4. Engineer receives $1.5M grant for nanoparticle cancer research
5. UC Riverside bioengineer receives high honor from chemical engineers
6. Pitt receives $2.5 million to simulate and analyze brain, immune system activity
7. NJIT biomedical engineer receives NSF Career Development Award
8. Monash researcher receives prestigious Commonwealth Health Ministers award
9. Spradling receives Gruber Foundation Genetics Prize for new genetic techniques
10. UNH receives $380,000 grant to study organic dairy as closed ecosystem
11. Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/25/2014)... that there are 133 active fires in the North Slave ... in the past 24 hours. Fire danger is moderate to ... , The Birch Lake Complex of fires are in an ... within 30 km north of Fort Providence. Four crews ... Moraine Point this week. Mop-up continues many areas of complex,s ...
(Date:8/25/2014)... The Happy Camp Complex of fires began as a lightning ... consumed 22,670 acres and is 20% contained. There ... present. It consists of many small fires and a ... have been contained and only account for about 100 acres. ... the morning and early afternoon on August 24, keeping fire ...
(Date:8/25/2014)... August 25, 2014 Nearly 1 in 6 adults ... time, the disorder can cause serious complications. Auriculotherapy, ... points on the outer ear, may help in ... between 2007-2013 that evaluated the effectiveness of auriculotherapy ... discussed in a Review article in The ...
Breaking Biology News(10 mins):Happy Camper and July Fire Complexes in California 2
... ANN ARBOR, Mich. The risk of esophageal cancer ... is not as high as many may think, according ... GERD is considered a relative risk for developing esophageal ... Joel Rubenstein, M.D., M.Sc., an investigator with the Department ...
... -- When their razor-sharp mandibles wear out, leaf-cutter ants ... sisters take over cutting, say researchers from two Oregon ... regular publication in the journal Behavioral Ecology and ... of providing for its displaced workers. "This ...
... can dive for anything up to 15 minutes. However, Bob ... blue whales may be able to dive for longer, because ... blood and muscles, so why don,t they? ,The theory was ... lot of energy, says Shadwick. Explaining that the whales feed ...
Cached Biology News:Esophageal cancer risk lower than expected for patients with GERD 2When their tools get dull, leaf-cutters switch jobs 2When their tools get dull, leaf-cutters switch jobs 3Blue whale-sized mouthfuls make foraging super efficient 2
(Date:8/26/2014)... , Aug. 26, 2014  ViveBio, LLC ... sample collection, stabilization and transportation, announced today that ... Procurement Services, LLC (LPS) of Knoxville, ... products in the United States ... class of ambient temperature dried biological specimen transport ...
(Date:8/26/2014)... Francisco, CA (PRWEB) August 26, 2014 ... reach USD 8,020.1 million by 2020, according to a ... for personalized medicine and theranostics, and the subsequent introduction ... key factors driving market growth over the next six ... and chronic diseases such as cancer, coupled with disease ...
(Date:8/26/2014)... Aug. 26, 2014 Trovagene, Inc. (NASDAQ: ... Dx Summit; Moving Assays to the Clinic ... Monitoring of Cell Free Tumor DNA in Urine." ... of its Precision Cancer Monitoring (PCM) platform and ... for the detection of tumor DNA mutations from ...
(Date:8/26/2014)... NEW YORK , Aug. 26, 2014  That,s ... life science markets, today announced the formation of a ... strategic content development. The expanded team will combine current ... messaging areas at That,s Nice. ... Strategic Content to lead the team. Tiene was previously ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3
... VENTURA, Calif., Dec. 12 VivoMetrics Inc., a ... the,appointment of Howard R. Baker to the position ... Paul Kennedy, who will remain with,the company in ... Baker joins VivoMetrics with over 28 years in ...
... Oral Iclaprim, "Rolling" NDA for Intravenous Iclaprim in cSSSI; Electronic ... First Modules ... Arpida Ltd,(SWX: ARPN) announced today the enrolment and dosing of ... iclaprim in the treatment,of hospital-acquired pneumonia (HAP) / ventilator-associated pneumonia,(VAP) ...
... for the First Time on 50 mg/Day Dose for PRISTIQ ... Treatment of ... a division of Wyeth (NYSE: WYE ), announces that ... serotonin-norepinephrine reuptake inhibitor (SNRI), showed,that adult patients who received a ...
Cached Biology Technology:VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer 2First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 2First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 3First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 4First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6
... The Dodeca silver stain kits are ... devices including Bio-Rad Dodeca stainers. This ... quantities of proteins in polyacrylamide gels ... kit includes sensitizer concentrate, silver reagent ...
The AVR9-8 stream-select valve is a 9-port, 8-position valve for use with the BioLogic DuoFlow system. This valve is used for high-pressure stream selection....
... stain for staining RNA (bluish-purple), DNA (blue), proteins (red) ... ≥ 90 % Cation traces: Ca ≤ 10 mg/kg ... ≤ 5 mg/kg Cu ≤ 5 mg/kg Fe ≤ ... mg/kg Mn ≤ 5 mg/kg Na ≤ 50 mg/kg ...
... Biometras Tpersonal thermocycler provides maximum performance ... generation of Peltier elements, high heating and ... to short run times. With a maximum ... Tpersonal provides half the capacity of much ...
Biology Products: